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In recent years, different investigations support the importance
of probiotics as apart of healthy diet for humans and animals
and as a way to provide a natural, safe and effective barrier
against microbial infections (Angmo et al., 2016; Oh and
Jung, 2015). According to the definition by the World Health
Organization (WHO), probiotics are ‘‘live microbial food sup-
plements which, when administered in adequate amounts con-
fer a health benefit on the host” (FAO/WHO, 2001). Among
the usually used microorganisms, lactic acid bacteria (LAB)
are regarded as a major group of probiotic bacteria (Collinsand Gibson, 1999). They are non-pathogenic, technologically
suitable for industrial processes, acid tolerance, bile tolerance
and produce antimicrobial substances (Mojgani et al., 2015).
They are classified as generally recognized as safe (GRAS)
microorganisms because of their long and safe use as starter
cultures in fermented products.
Nowadays, most probiotic bacteria are belonging to the
genera Lactobacillus and Bifidobacterium (Prasad et al.,
1998). However, species belonging to the genera Lactococcus,
Enterococcus and Saccharomyces (Salminen and von Wright,
1998; Sanders and in’t Veld, 1999) are also considered as pro-
biotic microorganisms.
According to the guidelines for the evaluation of probiotics
in food reported by a Joint FAO/WHO working group (Vijaya
et al., 2015), two of the currently most widely used in vitro tests
are resistance to gastric acidity and bile salts, as based on both
survival and growth studies. Other functional properties used
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compounds and cholesterol removal (Park et al., 2007; Xie
et al., 2015). The mechanism through which probiotics may
antagonize pathogens involves production of antimicrobial
compounds such as lactic acid, acetic acid, hydrogen peroxide
and bacteriocins.
Certain studies showed that among the other effects of pro-
biotic include, consumption of lactic acid bacteria reduced car-
riage of pathogens microorganism, decreased certain risk
factors for coronary artery disease, and resulted in a dose-
dependent reduction in the symptoms of Irritable bowel syn-
drome (Vries et al., 2006). It seems that, in the research for
strains with probiotic potential, food might also be a good
source of suitable isolates for finding new probiotic strains
for functional food products. Several probiotics bacteria are
found to produce bile salt hydrolase (BSH) that helps to
reduce serum cholesterol (Miremadi et al., 2014) and hence
BSH activity is also considered as an additional criterion for
the selection of probiotics. The aim of the present study was
to isolate, identify and screen for potential probiotic lactic acid
bacteria with high cholesterol capacity and bile salt hydrolase
activity.
Materials and methods
Collection of samples
Samples were collected from the normal habitats of lactic acid
bacteria (LAB) such as raw animal milk, fermented foods
(Boza, Zabady, Rayeb), cheese (Ras, Kareish), calves infant
faeces and intestinal of marine fish (Table 1). Samples were
transported to the laboratory in ice box and stored at ﬃ 4 C.Table 1 Isolation sources of lactic acid bacteria.
Isolation
Sources
Number of
examined
samples
Number
of
isolates
Location
Boza (BO) 2 43 Manfalut City, Assiut
Governorate, Egypt
Tanta city, Gharbia
Governorate, Egypt
Calves
infants
faeces (F)
2 10 Private farm,
Damanhour city,
Beheira Governorate,
Egypt
karish cheese
(k)
3 20 Alexanderia, local
markets
Milk (M) 2 10 Alexanderia, local
markets
Ras cheese
(R)
3 15 Alexanderia, local
markets
Rayeb Milk
(RM)
2 19 Alexanderia, local
markets
The
intestines of
marine fish
(I)
2 0 Alexanderia, local
markets
Zabady (Z) 4 25 Alexanderia, local
markets
Total 20 142Isolation of lactic acid bacteria
Milk samples were incubated at 30 C; 37 C; 42 C, while
samples of cheese, Zabady and Rayeb were cultured in steril-
ized reconstituted skim milk and incubated until coagulation.
Coagulated samples were then streaked on over agar surface
of MRS medium (De Man et al., 1960) and were incubated
anaerobically at 30 C, 37 C or 42 C for 48 h. Boza, calves
infant faeces and intestine of marine fish samples, were diluted
serially from 101 to 107, then 0.1 ml aliquot of the higher
dilutions (104 to 107) were spread on to MRS plates and
incubated at 30, 37 and 42 C for 48 h.
White and creamy colonies were picked up randomly and
purified by three successive transfers on MRS medium. The
cultures were routinely checked for purity by microscopic
examination.
The pure cultures were characterized using Gram stain, cell
morphology and catalase reaction according to standard pro-
cedures (Sharpe, 1979). Gram-positive and catalase-negative
isolates were selected and stored at 80 C in MRS broth plus
28% glycerol (El-Soda et al., 2003). The purified cultures were
activated by subculturing twice in MRS broth before use.
Antimicrobial activity assays
Screening of LAB isolates for antimicrobial activity
The Antimicrobial activity spectrums of cells free supernatants
of (LAB) isolates were determined against ten pathogens
(Table 2) using spot-on-lawn method (Barefoot and
Klenhammer, 1983). LAB isolates were cultivated in MRS
for 16-18 h with 1% inoculum then cells were removed from
MRS medium by centrifugation (6500g for 10 min, 4 C) to
obtain cell free supernatant. Lawns of pathogenic strains were
prepared by adding 0.125 ml (2  107 cell/ml) of 10 diluted
overnight culture to 5 ml of corresponding soft agar (Table 2).
The contents of the tubes were gently mixed and poured over
the surfaces of pre-poured MRS agar plates. Ten microliter of
each cell free supernatant was spotted onto the surface of the
soft agar plate and after 24 h of incubation, the plates wereTable 2 Indicator strains and their growth conditions.
Pathogenic microorganisms Medium and growth
temperature
Bacillus subtilis DB 100 host Nutrient Broth, 37 C
Candida albicans ATCC MYA-2876 YPDa Broth, 37 C
Clostridium botulinum ATCC 3584 TPGYb Broth, 37 C
Escherichia coli BA 12296 isolated by
dr sobhy
LBc Broth, 37 C
Klebsiella pneumoniae ATCC12296 LBc Broth, 37 C
Salmonella senftenberg ATCC 8400 Nutrient Broth, 37 C
Staphylococcus aureus NCTC 10788 Nutrient Broth, 37 C
Staphylococcus epidermidis Nutrient Broth, 37 C
Streptococcus dysgalactiae subsp.
Equisimilis
Nutrient Broth, 37 C
Streptococcus pyogenes Nutrient Broth, 37 C
a YPD broth: Yeast peptone dextrose.
b TPGY broth: tryptone–peptone–glucose–yeast extract.
c LB broth: Luria-Bertani medium.
Screening of probiotic lactic acid bacteria 67checked for the appearance of an inhibition zone. Clear zones
around the spots indicate the antimicrobial activity of isolated
bacteria.
Quantification of antimicrobial activity
Antimicrobial activity in the supernatant was determined by
an adaptation of the critical two fold dilution method
(Parente et al., 1994). Each tested isolate was subcultured in
MRS for 24 h, counted and adjusted to give 109 cell/ml. The
culture was used to inoculate (1%) fresh MRS and propagated
for 24 h. Supernatant was obtained by centrifugation (9000g
for 15 min). Serial two-fold dilutions of supernatant were car-
ried out in MRS. Activity was quantified by taking the recip-
rocal of the highest dilution that exhibited a clear zone of
inhibition and was expressed as activity units (AU) per millil-
itre of culture media. The titre of the antibacterial substance, in
AU/ml, was calculated as (1000/d) D, where D is the dilution
factor and d is the amount of supernatant in ll (Parente
et al., 1994).
Acid tolerance
Isolates of LAB were propagated twice in MRS broth (1% v/v)
for 20 h at 37 C before experimental use. The cells from
100 ml MRS culture were harvested by centrifugation
(4300g, 10 min), and washed three times in phosphate-
buffered saline, pH 7.0. Washed cell pellets were then sus-
pended in (1/10) cultivation volume in the same buffer, hence
obtaining a 10-fold increase in cell density. To 1 ml of the
washed cell suspension, 5 ml of simulated gastric juice and
1.5 ml NaCl (0.5 w/v) were added. Simulated gastric juice
was prepared freshly daily by suspending pepsin (3 g/L) in ster-
ile saline (0.5% w/v) and adjusting the pH to 2.0 with concen-
trated HCl (Charteris et al., 1998). The materials were
vortexed for 10 s and incubated at 37 C for 3 h. Aliquots of
0.1 ml were then removed at constant intervals (0, 1, 2, 3 h)
for determination of total viable count. Dilutions were made
(up to 104) and cells were plated in duplicate on MRS agar.
Plates were incubated at 37 C for 72 h before enumeration
(Charteris et al., 1998).
Bile tolerance
Bile containing MRS broth was prepared by the addition of
0.3 (v/v) of bile salt (Bio Basic Canada INC.). The cells from
100 ml (20 h MRS tested culture) were collected by centrifuga-
tion (3400g, 10 min), washed twice in saline (8.5 g NaCl/L) and
resuspended in 10 ml MRS broth. This suspension was inocu-
lated (1%) into MRS broth lacking or containing bile salt.
After 0, 1, 2 and 3 h of incubation at 37 C, viable counts on
MRS agar plates and absorbance of the culture at 625 nm were
determined (Matijasic and Rogelj, 2000). Experiments of acid
and bile tolerance were repeated three times each with dupli-
cate analysis.
Phenol tolerance
Phenol tolerance experiments were performed as described by
Aswathy et al. (2008) with slight modifications. The overnightcultures of LAB isolates were inoculated (1%) into MRS broth
with (0.2 and 0.5% v/v) or without phenol. Bacterial cells in
the culture broth were measured by reading the absorbance
(A) at 600 nm after 24 h of incubation at 37 C. The experi-
ments were repeated twice in duplicate.
Cholesterol assimilation
Freshly prepared MRS broth, supplemented with 0.3% oxgall
(Bio Basic Canada INC.) as bile salt and filter sterilized water
soluble cholesterol (100 lg/ml), was inoculated with each iso-
late at 1% level and incubated anaerobically at 37 C for
24 h. After incubation period, cells were removed by centrifu-
gation (9000g for 15 min) and the remaining cholesterol in the
spent broth was determined calorimetrically using o-
phthalaldehyde method described by Rudel and Morris
(1973). One millilitre of the cell- free broth was added to
1 mL of KOH (33% wt/vol) and 2 mL of absolute ethanol,
vortexed for 1 min, followed by heating at 37 C for 15 min.
After cooling, 2 mL of distilled water and 3 mL of hexane were
added and vortexed for 1 min. One millilitre of the hexane
layer was transferred into a glass tube and evaporated in water
bath at 65 C. The residue was immediately dissolved in 2 mL
of o-phthalaldehyde reagent. After complete mixing, 0.5 mL
concentrated sulphuric acid was added and the mixture was
vortexed for 1 min. Absorbance was read at 550 nm (T80
UV/Vis spectrometer PG Instruments LDT, United Kingdom)
after 10 min. All experiments were replicated twice.
Screening of probiotic LAB for bile salts hydrolases activity
(BSH)
Qualitative determination of bile salts hydrolases activity
The BSH activity was determined as described by Du Toit
et al. (2003). The LAB isolates were grown on MRS agar
plates containing 0.5% (w/v) taurodeoxycholic acid sodium
salt (TDCA; Sigma, USA) and 0.037% calcium chloride.
Plates were incubated under anaerobic conditions at 37 C
for 72 h. The precipitation zone surrounding colonies indicated
the bile salt hydrolase activity of bacteria.
Quantitative determination of bile salts hydrolases activity
The BSH activity was determined by measuring the amount of
amino acid liberated from conjugated bile salts, by the probi-
otic isolates as described by Tanaka et al. (2000) with several
modifications. Briefly, from cultures grown for 20 h at 37 C,
cells were harvested by centrifugation at 9700g for 15 min,
washed twice with 0.1 M sodium phosphate buffer containing
10 mM dithiothreitol (DTT), pH 6.8 and re-suspended in the
same buffer to obtain a suspension with an optical absorbance
(A600 nm) of 3.0. Cell suspension was sonicated for 60 s. with
cooling on ice with two cycles of 16 mm using a sonicator
(Sonics and Materials Inc., Vibro cell), followed by centrifuga-
tion at 9700g for 15 min. The reaction mixture consisted of
180 mL of 0.1 M sodium phosphate buffer, pH 6.0, 10 mL of
a 200 mM appropriate conjugated bile salt, 10 mM DTT and
10 mL of cell-free extract. The reaction mixture was incubated
at 37 C for 30 min., then a sample (100 lL) was taken and
200 lL of 15% (w/v) trichloroacetic acid was added to termi-
nate the reaction. The sample was centrifuged (9700g for
15 min) and 200 lL of the supernatant was added to 200 lL
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hydrin, 1.2 mL glycerol, and 0.7 mL 0.5 M pH 5.5 sodium
citrate buffer). The mixture was vortexed and boiled for
14 min. After subsequent cooling, the absorbance at 570 nm
was determined using glycine or taurine as standard. One unit
of BSH activity (U/ml) was defined as the amount of enzyme
that liberated 1 mmol of amino acid from the substrate per
min. Protein concentration was determined by the Lowry
method (Lowry et al., 1951), with bovine serum albumin
(Sigma) as standard. All experiments were repeated twice.
Identification of the promising LAB isolates
Phenotypic characterization
The promising LAB isolates were phenotyped as described in
Bergey’s manual of systematic bacteriology (Logan and De
Vos, 2009). The following tests were applied: cell morphology;
growth at 15, 37 and 45 C; and growth in MRS containing
2.5%, 4% and 6.5% NaCl. Fermentation patterns were deter-
mined using API 50 CHL and API 20 kits (Biomerieux SA,
France) according to the manufacturer’s instructions.
Molecular identification
Extraction of bacterial DNA. The DNA extraction and purifi-
cation from bacterial isolates were carried out according to the
procedure described by Cheng and Jiang, 2006. Overnight bac-
terial cultures were centrifuged individually at 15,000g for
10 min. Pellets were washed with 400 ll SET buffer (75 mM
NaCl, 25 mM EDTA, 20 mM Tris, pH 7.5), then centrifuged
at 10,000g for 10 min. The pellets were resuspended in TE buf-
fer (Tris-EDTA buffer, pH 8.0), 100 ll tris-saturated phenol
(pH 8.0) was added and the suspensions were centrifuged at
10,000g for 10 min at 4 C. Mixtures composed each of
160 ll of the obtained aqueous phase, 40 ll TE buffer and
100 ll chloroform were centrifuged at 10,000g for 10 min.
The resulting supernatant (100 ll) was mixed with 40 ll TE
buffer and 5 ll RNase (10 mg/ml) and incubated at 37 C for
10 min. Then 100 ll chloroform was added and the mixture
was centrifuged at 15,000g for 10 min at 4 C. The purity as
well as the yield of DNA in the aqueous phase was assessed
spectrophotometrically.
Polymerase chain reaction amplification. Universal primers
identifying LAB, designed using the invariant region in the
16 s rDNA sequences for LAB (Wang et al., 1996), were
obtained from Sigma Scientific Services Co., Germany. The
reaction mixture (20 ll) consisted of 5 ll colourless GoTaq
reaction Buffer (5), 0.25 ll GoTaq DNA Polymerase
(5 u/ll) (Promega, USA), 2.5 ll PCR nucleotide Mix
(10 mM), 1 ll of each primer 5/CGTGCCAGCCGCGGTAA-
TACG 3/and 5/GGGTTGCGCTCGTTGCGGGACT
TAACCCAACAT 3/) as forward and reverse primers, respec-
tively, 2 ll genomic DNA and 8.25 ll of nuclease-free water.
The PCR amplification was carried out in the thermo cycler
PCR (Santa Clara, California, United States) according to the
following programme: initial denaturation at 95 C for 5 min,
amplification for 30 cycles [95 C/40 s (denaturation),
55 C/40 s (annealing), 72 C/1 min (extension)], then final
extension at 72 C for 10 min. The products were separated
on 1% agarose gel containing ethidium bromide (1 lg/ml),
then image was taken using gel documentation system(Syngene Bio Maging, Canada). The DNA marker 100–
1500 bp (TAKARA BIO INC., Shiga, Japan) was used as
the molecular weight standard.
Sequencing of DNA. The DNA sequencing reactions were per-
formed using an automated DNA sequencer. Database
searches were performed using the latest release of non-
redundant DNA sequence database present at the National
Centre for Biotechnology Information (NCBI) website located
at: http://www.ncbi.nlm.nih.gov/BLAST (Altschul et al.,
1997).
Statistical analysis
Data were statistically analysed with CoStat software (version
6.303). One-way analysis of variance was used to study signif-
icant difference between means, with significance level at
P= 0.05.
Results and discussions
Screening of LAB isolates for their antimicrobial activity
One hundred and forty-two LAB were isolated from various
sources (Table 1). All isolated bacteria fit the classification of
LAB as Gram-positive, catalase negative (Sharpe, 1979). The
antimicrobial activity is one of the most important selection
criteria for probiotic. The LAB isolates were screened for pro-
duction of antimicrobial agents against 10 pathogens
(Table 2).
Out of 142 LAB isolates only 68 isolates exhibited antago-
nistic activity with varying degrees. Out of sixty LAB strains
isolated from zabady and cheese samples, only thirty-eight
strains showed inhibitory activity against the tested pathogens.
No antagonistic activity could be observed for LAB strains
isolated from milk and calves infant faeces. The LAB strains
that showed inhibitory activity against more than six of the
tested pathogens were isolated from Boza and Rayebmilk sam-
ples. On the other hand, LAB isolates obtained from zabady,
Ras cheese and Karish exhibited antagonistic activity only
against three or less of the tested pathogens. Indicator patho-
gens can be organized in descending order according to their
sensitivity to the tested isolates as follows: Escherichia coli
BA 12296 was sensitive to 41 isolates while Staphylococcus epi-
dermidis, Salmonella senftenberg ATCC 8400, Staphylococcus
aureus NCTC 10788, Streptococcus pyogenes, Klebsiella pneu-
moniae ATCC12296, Candida albicans ATCC MYA-2876,
Streptococcus dysgalactiae subsp. equisimilis, and Bacillus sub-
tilis DB 100 were sensitive to 28,29,23,19,15,14,10,2 of LAB
isolates, respectively.
All isolates with antimicrobial activity against any of the
tested pathogens (68 isolates) were selected for quantitative
determination of their antimicrobial activities (Table 3).
Among 68 isolates, only 9 isolates showed wide spectrum
activity against four tested pathogens at least.
Among the nine isolates of LAB, only one isolate (RM39)
showed strong activity of 1600 AU/ml against Klebsiella pneu-
moniae ATCC12296 while, four isolates exhibited inhibitory
activity of 800 AU/ml against each of Escherichia coli
(BO51); Streptococcus pyogenes (RM28); Staphylococcus aur-
eus NCTC 10788 (BO3, RM3), Salmonella senftenberg ATCC
Table 3 Antimicrobial activities of cell-free supernatants of 68 selected LAB isolates against various pathogens.a
Isolate no Sym Sources Incubation T (C) Antimicrobial activity against pathogens expressed in AU/mlc
Bac Cand. Clo. E. coli Kleb. Sal. St.au. St.epi St.Py. St. dy.
1. dBO3 BOb 30 0 0 0 400 0 400 800 200 200 400
2. BO4 BO 30 0 0 0 200 0 200 0 0 0 0
3. BO5 BO 30 0 0 0 200 0 0 0 200 0 0
4. BO6 BO 30 0 0 0 200 0 0 0 0 0 0
5. BO7 BO 30 0 0 0 400 800 200 0 0 0 0
6. BO8 BO 30 0 0 0 200 0 200 0 200 0 0
7. BO12 BO 30 0 0 0 200 0 200 0 200 0 0
8. BO22 BO 37 0 0 0 200 0 200 0 200 0 0
9. BO24 BO 37 0 0 0 200 0 200 0 200 0 0
10. BO27 BO 37 0 0 0 200 0 200 0 200 0 0
11. BO29 BO 37 0 0 0 200 0 200 0 200 0 0
12. BO30 BO 37 0 0 0 200 0 200 0 200 0 0
13. BO31 BO 37 0 0 0 200 0 200 0 200 0 0
14 BO33 BO 37 0 0 0 200 400 400 0 0 0 0
15. bBO34 BO 37 200 0 0 800 800 400 0 0 0 0
16. dBO35 BO 37 0 0 0 800 200 800 200 200 0 200
17. BO36 BO 37 0 0 0 400 0 0 200 400 0 0
18. dBO37 BO 37 800 0 0 400 0 200 200 800 400 400
19. BO42 BO 42 0 0 0 400 200 0 0 400 0 0
20. BO44 BO 42 0 0 0 0 200 400 0 0 400 0
21. BO45 BO 42 0 0 0 200 0 200 200 0 0 0
22. BO46 BO 42 0 0 0 200 0 200 200 0 0 0
23. BO50 BO 42 0 0 0 0 0 200 200 0 200 0
24. dBO51 BO 42 0 400 0 800 200 200 200 400 200 400
25. dBO52 BO 42 0 0 0 400 400 0 0 400 0 400
26. Z1 Zb 30 0 0 200 0 0 0 200 0 200 0
27. Z2 Z 30 0 0 200 0 0 0 200 0 200 0
28. Z3 Z 30 0 0 0 0 200 0 0 200 200 0
29. Z4 Z 30 0 0 0 200 0 0 200 0 200 0
30. Z5 Z 30 0 0 0 0 0 0 0 0 200 0
31. Z8 Z 30 0 0 0 0 200 0 0 0 200 0
32. Z9 Z 30 0 0 0 0 200 0 0 0 0 200
33. Z22 Z 37 0 200 0 400 0 0 0 0 0 0
34. Z23 Z 37 0 0 0 0 200 200 0 0 0 200
35. Z25 Z 37 0 0 0 0 0 400 400 0 0 0
36. Z27 Z 37 0 0 0 200 0 0 200 0 0 0
37. Z28 Z 37 0 0 0 0 200 0 200 400 0 0
38. Z39 Z 37 0 200 0 0 0 0 200 400 0 0
39. Z41 Z 42 0 0 0 0 0 200 200 200 0 0
40. Z42 Z 42 0 0 0 200 0 0 200 200 0 0
41. R20 Rb 37 0 0 0 200 0 0 0 200 0 0
42. R22 R 37 0 0 0 200 0 0 200 0 0 0
43. R24 R 37 0 0 0 200 0 0 200 0 0 0
44. R25 R 37 0 0 0 0 200 200 0 400 0 0
45. R26 R 37 0 0 0 0 0 200 0 0 200 0
46. R27 R 37 0 200 0 0 0 0 200 0 0 0
47. R28 R 37 0 200 0 0 0 0 0 0 0 0
48. R34 R 37 0 0 0 0 0 0 200 200 0 0
49. K1 Kb 30 0 0 0 200 0 0 200 0 0 0
50. K2 K 30 0 0 0 0 0 0 0 0 400 0
51. K4 K 30 0 0 0 0 0 0 200 200 0 0
52. K5 K 30 0 200 0 0 0 0 200 0 400 0
53. K6 K 30 0 0 0 200 0 0 0 0 200 0
54. K7 K 30 0 0 0 0 0 200 0 0 200 0
55. K8 K 30 0 0 0 200 0 0 0 0 0 0
56. K9 K 30 0 200 0 0 0 0 400 0 0 0
57. K23 K 37 0 200 0 200 0 0 0 0 200 0
58. K24 K 37 0 0 0 0 0 0 0 0 0 200
59. K26 K 37 0 200 0 0 0 0 0 0 200 0
60. K27 K 37 0 200 0 200 0 0 0 0 0 0
61. K40 K 42 0 0 0 200 0 0 0 0 0 0
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Table 4 Survival of selected lactic acid bacteria isolates under simulated gastric juice conditions at 37 C.
Isolates code Mean of viable count (log10 CFU ml
1) ± SD* Surviving percentage (%)
Time of exposure (h)
0 1 2 3
Bo 3 8.29 ± 0.41a 7.80 ± 0.14bcd 7.04 ± 0.20cd 6.32 ± 0.25d 76.2
Bo 34 8.31 ± 0.29a 7.91 ± 0.03bc 7.21 ± 0.16bc 6.37 ± 0.08d 76.6
Bo 35 8.17 ± 0.317a 7.60 ± 0.23cde 7.36 ± 0.27bc 7.22 ± 0.28ab 88.3
Bo 37 8.55 ± 0.22a 7.86 ± 0.04bcd 7.51 ± 0.14ab 7.33 ± 0.13a 85.7
Bo 51 8.37 ± 0.25a 7.55 ± 0.07de 7.13 ± 0.10cd 6.45 ± 0.38cd 77
Bo 52 8.37 ± 0.44a 8.33 ± 0.45a 7.57 ± 0.17ab 6.59 ± 0.24cd 78.7
RM 3 8.35 ± 0.34a 7.28 ± 0.17e 6.81 ± 0.19de 6.81 ± 0.19bc 81.5
RM 28 8.41 ± 0.44a 7.58 ± 0.13cde 6.60 ± 0.41e 5.72 ± 0.27e 68
RM 39 8.37 ± 0.28a 8.03 ± 0.20ab 7.85 ± 0.09a 6.48 ± 0.30cd 77.4
abcdeMeans in the same column followed by different superscript letters are significantly different (P< 0.05).
BO: – Boza & RM: – Rayeb Milk.
* Results are expressed as mean ± SD, and each value is the average of three experiments and each was carried out in duplicate.
Table 3 (continued)
Isolate no Sym Sources Incubation T (C) Antimicrobial activity against pathogens expressed in AU/mlc
Bac Cand. Clo. E. coli Kleb. Sal. St.au. St.epi St.Py. St. dy.
62. K42 K 42 0 200 0 200 0 0 0 0 200 0
63. K43 K 42 0 200 0 0 0 0 0 0 200 0
64. RM1 RMb 30 0 0 0 200 200 200 0 0 0 0
65. dRM3 RM 30 0 1600 0 400 200 0 800 200 200 800
66. RM26 RM 30 0 0 0 0 200 0 0 200 200 0
67. dRM28 RM 30 0 0 0 400 200 800 200 400 800 0
68. dRM39 RM 30 0 200 0 400 1600 400 200 400 0 400
a Bac.: – Bacillus Subtilis; Cand.: – Candida albicans; Clo.: – Clostridium botulinum; E. coli: – Escherichia coli; Kleb.: – Klebsiella pneumoniae;
Sal.: – Salmonella Senftenberg; St.au.: – Staphylococcus aureus; St.epi.: – Staphylococcus Epidermidis; Str. pyo.: – Streptococcus pyogenes; St.
dy.: – Streptococcus dysgalactiae subsp. Equisimilis.
b Sources of isolation: BO: Boza; Z: Zabady; R: Ras cheese; K: karish cheese; RM: Rayeb Milk.
c Activity units/ml cell-free supernatant was calculated according to the following equation: (1000/d)  D ،Where D is the two-fold dilution
factor, d is the amount of supernatant used.
d Isolates had antimicrobial activity against 4 or more pathogenic microorganisms.
70 M.G. Shehata et al.8400 (RM28). Growth of pathogens is inhibited by the produc-
tion of antimicrobial compounds such as organic acids, hydro-
gen peroxide, diacetyl and bacteriocins by LAB as well as their
competition for nutrients (Bezkorvainy, 2001; Tambekar et al.,
2009).The nine promising LAB isolates were examined for fur-
ther probiotic criteria such as bile, acid and phenol tolerance as
well as their cholesterol removal capacities.
Tolerance to acid and bile
As probiotics are usually administrated orally, they must have
the ability to survive passage through the stomach and small
intestine. Therefore, resistance to the low pH of the gastric
juice in the stomach and the bile salt in the small intestine is
one of the important selection criteria for probiotic (Olejnik
et al., 2005). In the present study, all the selected LAB isolates
were able to survive simulated gastric juice at pH 2 after 3 h of
incubation (Table 4). They retained varying levels (68–88.3%)
of viability. The highest survival was for BO35 isolate while the
least survival was observed for RM28 isolate.
Acid tolerance of bacteria is important not only for with-
standing gastric stresses, but also a prerequisite for their useas dietary adjuncts and enables strains to survive for longer
period of time in high acid carrier food without larger reduc-
tion in humans (Conway et al., 1987; Prasad et al., 1998).
Tolerance to bile salts is a prerequisite for colonization and
metabolic activity of bacteria in small intestine of the host
(Havenaar et al., 1992). This will help Lactobacillus spp. and
Lactococcus spp. to reach the small intestine and colon and
contribute in balancing the intestinal microflora (Tambekar
and Bhutada, 2010). All the tested strains exhibited bile toler-
ance with varying degrees. Among the tested LAB isolated in
the present study, BO34 isolate demonstrated the highest bile
salt tolerance followed by BO52 isolate (Table 5).
Phenol tolerance
For a strain to be a probiotic, it has to survive the action of
toxic metabolites, primarily phenols, produced during the
digestion process (Hoier, 1992). Some aromatic amino acids
derived from dietary or endogenously produced proteins can
be deaminated in the gut by bacteria leading to the formation
of phenols which have bacteriostatic properties (Suskovic
et al., 1997).
Table 5 Survival of selected lactic acid bacteria isolates in MRS broth supplemented with 0.3% bile salts after 0, 1, 2 and 3 h at 37 C.
Isolates code Mean of viable count (log10 CFU ml
1) ± SD* Surviving percentage (%)
Time of exposure (h)
0 1 2 3
Bo 34 8.05 ± 0.05a 7.63 ± 0.26ab 7.04 ± 0.21a 6.85 ± 0.10ab 85
Bo 35 7.98 ± 0.43a 6.77 ± 0.41d 6.54 ± 0.21c 5.69 ± 0.32d 71.3
Bo 51 8.25 ± 0.20a 6.81 ± 0.41cd 6.45 ± 0.42c 5.82 ± 0.45cd 69.8
Bo 52 8.41 ± 0.32a 7.98 ± 0.29a 7.24 ± 0.22a 6.85 ± 0.14a 81.4
Bo 37 8.36 ± 0.44a 8 ± 0.12a 7.39 ± 0.1a 6.57 ± 0.22ab 78.5
Bo 3 8.39 ± 0.39a 7.98 ± 0.33a 6.58 ± 0.40bc 6.35 ± 0.33abc 75.6
RM 39 8.2 ± 0.16a 7.36 ± 0.21bc 6.55 ± 0.06c 6.20 ± 0.65bcd 75.6
RM 28 8.19 ± 0.28a 7.51 ± 0.07ab 7.29 ± 0.06a 6.49 ± 0.40ab 79.2
RM 3 8.51 ± 0.46a 7.45 ± 0.54ab 6.99 ± 0.26ab 6.66 ± 0.17abc 78.2
abcde Means in the same column followed by different superscript letters are significantly different (P< 0.05).
BO: – Boza & RM: – Rayeb Milk.
* Results are expressed as mean ± SD, each value is the average of three experiments and each was carried out in duplicate.
Screening of probiotic lactic acid bacteria 71Fig. 1 illustrates the effect of two different phenol concen-
trations (0.2% and 0.5%) on the growth of nine LAB isolates
after 24 h of incubation in MRS medium at 37 C. The exam-
ined LAB isolates showed different degrees of sensitivity
towards different concentrations of phenol. The highest toler-
ance (95.89%) to 0.2% phenol concentration was demon-
strated for BO37 followed by RM39 (94.1%), while, BO52
had the lowest tolerance. At 0.5 phenol concentration, all the
tested LAB isolates exhibited varying relative growth percent-
age ranged between 15.1% and 21.7%. Vizoso Pinto et al.
(2006) observed varying degrees of sensitivity for four strains
of Lactobacillus johnsonii and six strains of L. plantarum
towards 0.4% phenol concentration while L. plantarum strains
were less sensitive.
Cholesterol removal by LAB isolates
Hypercholesterolemia (elevated blood cholesterol level) is con-
sidered a major risk factor for the development of coronary
heart disease. Therefore, lowering the serum cholesterol level
is important to prevent the disease. The cholesterol – removing0 
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Fig. 1 Effect of phenol concentration on the growth oability of LAB isolates was assessed in vitro in the presence of
oxgall after 24 h of anaerobic growth at 37 C (Fig. 2). All the
nine LAB isolates showed the ability to remove cholesterol
from the media. They exhibited varying degrees of cholesterol
lowering ability ranged from 8.4% to 43.5%. The BO37 isolate
manifested superior ability (43.75%) to remove cholesterol
from the medium which was significantly higher than those
of the other examined LAB isolates. The lowest value of
cholesterol assimilation was traced in BO35 isolate. The ability
of in vitro cholesterol level reduction in model culture media
has been shown for numerous strains of LAB (Pereira and
Gibson, 2002; Lavanya, 2001; Wang et al., 2012; Miremadi
et al., 2014). Further studies are required to determine the
mechanism(s) involved in the removal of cholesterol by those
probiotic LAB isolates.
Screening of LAB isolates for BSH activity
Qualitative determination of bile salts hydrolases activity
The ability of probiotic strains to detoxify bile salt by produc-
ing BSH enzyme activity has often been included among the51 Bo52 Bo35 RM3
cteria 
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Fig. 2 Cholesterol removal by LAB isolates. BO: – Boza & RM: – Rayeb Milk.
Fig. 3 The BSH activity of LAB isolates grown on bile salt – MRS medium as manifested by the formation of precipitation zone around
the colony. The code numbers 1–9 represent the LAB isolates as follows: 1: BO3; 2: BO34; 3: BO35; 4: BO37; 5: BO51; 6: BO52; 7: RM3; 8:
RM28; 9: RM39. BO: – Boza & RM: – Rayeb Milk.
72 M.G. Shehata et al.criteria for probiotic strain selection (Noriega et al., 2006). Bile
salt hydrolase is an enzyme that catalyses the deconjugation of
bile salt to liberate free primary bile acids (Gilliland and Speck,
1977).
When bile salt hydrolase producing LAB isolates were
streaked on MRS plates containing TDCA, the taurine conju-
gated bile acid was deconjugated producing deoxycholic acid.The deconjugation activity of LAB isolates was manifested in
Fig. 3, and copious amounts of deoxycholic acid precipitated
around active colonies and diffused into the surrounding
medium.
Out of nine LAB isolates previously selected based on their
high antimicrobial activity, eight isolates displayed BSH activ-
ity to different levels. Four isolates (BO35, BO37, BO52,
Table 7 Physiological characteristics of lactic acid bacteria
isolates.
Characteristics LAB isolates
BO
3
BO
34
BO
37
BO
51
BO
52
RM
28
RM
39
Gram strain + + + + + + +
Catalase
production
      
Glucose
fermentation
      
Growth:
Screening of probiotic lactic acid bacteria 73RM39) exhibited high BSH activity by providing large precip-
itation zones (2.03, 2.45, 2.25, and 1.98 mm, respectively)
around colonies on plate assay. Notwithstanding, the other
four isolates demonstrated low BSH activity by expressing
small (less than 1.5 mm) precipitation zones.
The presence of bile salt hydrolase (BSH) in probiotics ren-
ders them more tolerant to bile salts, which also helps to
reduce the blood cholesterol level of the host (Noriega et al.,
2006).
Contrary to the results of the present study, Begley et al.
(2006) reported that BSH activity has not been detected in bac-
teria isolated from environments from which bile salts are
absent. It is worthy to mention that all the eight BSH-
positive LAB isolates are not associated with gastrointestinal
environment.
Quantitative determination of bile salts hydrolases activity
The highest total BSH activity (3.09 u/ml) towards tauro-
cholate was displayed by RM39 LAB isolate compared with
other LAB isolates Table 6. In contrast, the lowest total
BSH activity (0.25 u/ml) was demonstrated for RM3 isolate.
Specific activity of BSH did not correlate well with total
BSH activity by most LAB isolates due to varying protein con-
tent in cell extracts. The RM39 and RM3 isolates had high
(3.09 u/ml) and low (0.25 u/ml) total BSH activity, respectively
and exhibited the same trend as well with respect to the specific
activity. Meanwhile, BO37 isolate that had high total BSH
activity (2.47 u/ml) displayed low specific activity (0.85 u/
mg). Similar results were reported by Liong and Shah (2005)
for lactobacillus strains towards different bile salts. Several
studies have indicated that the mechanism for in vitro removal
of cholesterol is linked to the bile salt hydrolase activity of pro-
biotic strains (Kimoto et al., 2002; Liong and Shah, 2005).
Moreover, the decomposition of bile salts by BSH enzyme
would disrupt the formation of the cholesterol micelle which
in turn prevents cholesterol absorption (Klaver and Van der
Meer, 1993).
From the genetic data, it was obvious that BSH is an intra-
cellular enzyme. This is consistent with the observation that noTable 6 BSH activity of lactic acid bacteria isolates on
sodium taurocholate.a
Isolates BSH activityb,c
Total protein
(mg/ml)
Total activity
(U/ml)
Specific activity
(U/mg)
Bo 34 1.22 ± 0.27b 1.64 ± 0.28d 1.34 ± 0.32a
Bo 35 2.62 ± 0.61a 2.31 ± 0.22bc 0.88 ± 0.25cd
Bo 37 2.89 ± 0.26a 2.47 ± 0.45b 0.85 ± 0.09d
Bo 51 1.08 ± 0.44b 0.67 ± 0.34e 0.62 ± 0.5e
Bo 52 2.14 ± 0.89a 1.95 ± 0.15cd 0.91 ± 0.52c
RM 3 0.42 ± 0.49b 0.25 ± 0.15ef 0.59 ± 1.19e
RM 28 2.54 ± 0.66a 2.25 ± 0.24bc 0.88 ± 0.16cd
RM 39 2.96 ± 0.11a 3.09 ± 0.27a 1.04 ± 0.13b
BO: – Boza & RM: – Rayeb Milk.
a Results are expressed as means ± standard deviation; values
are means of triplicate.
b BSH activity from cell free extracts of lactic acid bacteria iso-
lates grown on MRS broth supplemented with 6 mM sodium
taurocholate.
c Means in the same column followed by different superscript
letters are significantly different (P< 0.05).enzyme activity was present in the supernatants of overnight
cultures, while activity was released either by sonication or
other cell disruption methods or by lysis in assays performed
with whole cells due to the lytic properties of the bile salts
(Lunden and Savage, 1990; Grill et al., 1995; Tanaka et al.,
2000).
Identification of promising LAB isolates
Phenotypic characterization
The seven promising isolated strains (BO3, BO34, BO37,
BO51, BO52, RM28, RM39) are Gram positive, catalase neg-
ative, non-spore forming and fermenting glucose. All the iso-
lates are rod shaped except RM39 and BO37 that are
spherical cells. The physiological and biochemical characteris-
tics of the selected LAB isolates Table 7 are similar to those
described in Bergey’s Manual of Determinative of Bacteriol-
ogy (Logan and De Vos, 2009) for the genera Lactobacillus
and Lactococcus. Further, biochemical characterization using
API 50 CHL for Lactobacilli and API 20 for cocci showed
the similarity in characteristics with the corresponding identi-
fied LAB species (Table 8). Bill et al. (1992) and Klinger
et al. (1992) indicated that some commercial identification sys-
tems often yield good results regarding genus identification but
they were not fully adequate at the species level.15 C +  + + +  +
37 C + + + + + + +
45 C + +  + + + 
NaCl
2% + + + + + + +
4% + + + + + + +
6.5%   + + +  +
BO: – Boza & RM: – Rayeb Milk.
Table 8 Identification of LAB isolates by API 50 CHL and
API 20 kits.
Isolates Species identified by API test
BO 3 Lactobacillus rhamnosus
BO 34 Lactobacillus delbrueckii subsp. bulgaricus
BO 37 Lactococcus lactic subsp. lactis
BO 51 Lactobacillus paracasei
BO 52 Lactobacillus paracasei
RM 28 Lactobacillus gasseri
RM 39 Lactococcus lactic subsp. lactis
BO: – Boza & RM: – Rayeb Milk.
Fig. 4 PCR products for lactic acid bacteria isolates (BO37;
RM28; BO52; BO34; BO51; RM39 and BO3) in a 2% agarose gel.
Lane 1 (DNA Ladder from 100 bp to 1500 bp), lanes 2–7 (isolates
lactic acid bacteria). BO: – Boza & RM: – Rayeb Milk.
74 M.G. Shehata et al.Molecular identification
Molecular methods are important for bacterial identification
(Drancourt et al., 2000; Sghir et al., 2000; Greetham et al.,
2002; Heilig et al., 2002) and possibly more accurate for
LAB than the conventional phenotypic methods. In the pre-
sent study, 16sr-DNA of the total genomic DNA from promis-
ing LAB isolates was amplified and sequenced for
identification. Amplification using universal primer produced
a PCR product of approximately 600 bp (Fig 4). The sequenc-
ing data of purified 16S r-DNA of isolates were employed for
bacterial identification. The sequences of the selected isolates
were aligned with the 16S r-DNA sequences from the Gen-
Bank database (website) to identify the studied microorgan-
ism. 16S r-DNA sequencing data of the selected isolates
clearly showed (BO 3) 90% homology to Lactobacillus rham-
nosus & (BO 34) 96% homology to Lactobacillus delbrueckii
subsp. Bulgaricus & (BO 37) 99% homology to Lactococcus
lactic subsp. lactis & (BO 51) 100% homology to Lactobacillus
paracasei & (BO 52) 100% homology to Lactobacillus paraca-
sei & (RM 28) 100% homology to Lactobacillus gasseri and
(RM 39) 98% homology to Lactococcus lactic subsp. lactis.
Conclusion
In the present study, 142 LAB strains were isolated from dif-
ferent sources and only nine isolates were selected on the basis
of their high antagonistic activity. The nine promising LAB
isolates exhibited good resistance to gastrointestinal conditions
(pH, 2; bile salt, 0.3%; phenol 0.2–0.5%), high cholesterol
removal and expressed BSH activity. Among the promising
LAB isolates, BO37 which isolated from Boza and identified
as Lactococcus lactic subsp. lactis manifested the highestcholesterol removal ability (43.7%) and good BSH activity
(2.47 u/ml). Accordingly, owing to its good probiotic proper-
ties, this strain could be potentially used in functional food
and health products especially where cholesterol reduction in
food is the main target. Further in vivo study is necessary to
prove the hypocholesterolemic effect of the isolated Lactococ-
cus lactic subsp. lactis. Moreover in vitro studies are required
to determine the mechanism(s) involved in the reduction of
cholesterol by such a promising isolate.
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